DOI:
10.1055/s-00000068
Seminars in Interventional Radiology
LinksClose Window
References
Rosell R, Carcereny E, Gervais R , et al; Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica.
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.
Lancet Oncol 2012;
13 (3) 239-246
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.